Westrock Coffee Company (WEST) Q3 2024 earnings summary

Executive summary

• Achieved strong third quarter performance with year-over-year growth in key segments, despite a challenging macroeconomic environment and a net loss of $14.3 million for Q3 2024, mainly due to higher operating expenses and Conway facility start-up costs.

• Secured major new customer volume commitments for 2025, with over a dozen new customers onboarding at the Conway facility, expected to materially lift volumes and profits, especially in single-serve cups and RTD products.

• Completed numerous new contracts, providing greater clarity into monthly financial forecasts for 2025.

• Conway extract and RTD plant is essentially sold out for 2025, with production ramping up and additional capacity being marketed for 2026-2027.

• Appointed Ken Parent as Vice Chairman of the Board, bringing extensive operational and strategic experience.

Financial highlights

• Q3 2024 net sales were $220.9 million, nearly flat year-over-year, with a 7.2% decline in Beverage Solutions offset by a 32.8% increase in Sustainable Sourcing & Traceability.

• Consolidated gross profit increased to $37.1 million, with gross margin at 16.8% for Q3 2024.

• Net loss of $14.3 million for Q3 2024, compared to net income of $16.6 million in Q3 2023.

• Consolidated Adjusted EBITDA for Q3 2024 was $10.3 million, impacted by $4 million in Conway scale-up operating costs.

• Diluted EPS for Q3 2024 was $(0.16), compared to $0.15 in Q3 2023.

Outlook and guidance

• Expect to end 2024 at the low end of guidance, with Consolidated Adjusted EBITDA of $50 million, including $10 million in Conway scale-up costs.

• Preliminary 2025 guidance projects Consolidated Adjusted EBITDA between $80 million and $100 million, including $10–$15 million in Conway scale-up costs.

• 2025 growth drivers include new retail customers, increased single-serve volume commitments, cost reduction benefits, and rapid RTD can volume scale-up.

• Exit run rate for 2025 expected to be $125–$150 million, with full earnings power of current assets estimated at $150–$180 million.

• Management expects Conway facility capital expenditures to be completed by Q1 2025, with $30 million planned for the remainder of 2024.